CCK-BRs are present on activated pancreatic stellate cells or fibroblasts, and interruption of this signaling pathway decreases the genes implicated in epithelial to mesenchymal transition, invasion, and metastases in pancreatic cancer. The gene discussed is CCK; the disease is familial pancreatic carcinoma.